Related Experiment Video
Updated: May 15, 2025

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach
Published on: December 1, 2011
The utility of coproantigen testing in screening populations
K Wade Burton1, Helen Michael1, Corie Drake1
1IDEXX Laboratories, Westbrook, ME, USA.
A new coproantigen immunoassay is more effective than traditional fecal flotation for detecting intestinal parasites in dogs and cats, guiding necessary antiparasitic management.
Area of Science:
- Veterinary diagnostics
- Parasitology
- Immunodiagnostics
Background:
- Intestinal parasite detection is crucial for veterinary risk assessment.
- Fecal flotation for ova detection is the traditional method.
- New diagnostic tools are needed to improve accuracy and clinical utility.
Purpose of the Study:
- Evaluate the clinical utility of a commercial coproantigen immunoassay.
- Compare coproantigen testing with centrifugal fecal flotation (O&P).
- Assess the impact on clinical management decisions for GI parasite infections in companion animals.
Main Methods:
- Analysis of 898,299 paired fecal samples (coproantigen vs. O&P).
- Samples collected from a commercial reference laboratory over three months.
- Evaluation of test positivity and clinical management changes.
Main Results:
- 83.7% of samples were negative by both methods.
- Coproantigen detected infections missed by O&P in 9.4% of samples.
- O&P detected infections missed by coproantigen in only 0.6% of samples (excluding coprophagy).
Conclusions:
- Coproantigen immunoassay is more effective than O&P for identifying animals needing antiparasitic management.
- The coproantigen test is a highly accurate and effective screening method.
- Supports adoption of coproantigen testing for canine and feline intestinal parasitism.
More Related Videos
10:35A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
Published on: April 5, 2018
06:46A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022